<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01416818</url>
  </required_header>
  <id_info>
    <org_study_id>2008XYRCT</org_study_id>
    <nct_id>NCT01416818</nct_id>
  </id_info>
  <brief_title>Treatment of Depression in Parkinson's Disease</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled Study of &quot;Xiaoyao Pill&quot; Treatment of Depression in Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xuanwu Hospital, Beijing</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to evaluate the efficacy of Traditional Chinese Medicine-&quot;Xiaoyao
      Pill&quot; (Herb extracts)on depression, compared to placebo and &quot;Bupleurum+Ginkgo&quot; in patients
      with Parkinson's disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Depression as the most common non-motor comorbidity of Parkinson's disease (PD), have a
      negative impact on disability and quality of life.

      Traditional Chinese Medicine has shown effects on several depression. It is not known if TCM
      also is effective for depression in PD. This study is to investigate &quot;Xiaoyao Pill&quot;, an
      antidepressant in TCM, on depression in PD.

      A total of 60 patients with depression in PD will be randomized to each of the three arms.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2008</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">October 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Depression Scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change of Hamilton Depression Scale score on week 12 from baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the responder rate (defined as score reduction of HAMD-17&gt;=50%)</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the Geriatric Depression Scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>GDS-30</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Depression in Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>group 3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xiaoyao Pill</intervention_name>
    <description>herb extracts,were received two times a day for 12 weeks without dose changing.</description>
    <arm_group_label>group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupleurum+Ginkgo</intervention_name>
    <description>herb extracts, were received two times a day for 12 weeks without dose changing.</description>
    <arm_group_label>group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>The placebo looked like herb extracts and were also received two times a day for 12 weeks without dose changing.</description>
    <arm_group_label>group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parkinson's disease without dementia

          -  Depression

          -  Males or females

          -  Willing and able to give informed consent

        Exclusion Criteria:

          -  cognitive dysfunction

          -  other serious diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piu Chan, MD. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jinglin Zhang, MD, PhD.</last_name>
    <phone>+86-10-83198677</phone>
    <email>littlenumskull@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xuanwu Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piu Chan, M.D., Ph.D.</last_name>
      <phone>+86-10-83198677</phone>
      <email>pbchan@hotmail.com</email>
    </contact>
    <contact_backup>
      <email>pbchan90@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Piu Chan, MD,PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2011</study_first_submitted>
  <study_first_submitted_qc>August 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2011</study_first_posted>
  <last_update_submitted>August 11, 2011</last_update_submitted>
  <last_update_submitted_qc>August 11, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2011</last_update_posted>
  <responsible_party>
    <name_title>Piu Chan, MD, PhD.</name_title>
    <organization>Xuanwu Hospital</organization>
  </responsible_party>
  <keyword>Depression;</keyword>
  <keyword>Parkinson's disease;</keyword>
  <keyword>antidepressant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>November 30, 2013</submitted>
    <returned>January 15, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

